Platform for rapid innovation

New agreement between Harvard and Facebook streamlines research collaborations

Driven by Curiosity

The new agreement facilitates the interactions and collaborations that arise from intellectual cross-pollination. X

Transforming Stem Cell Transplants

Startup licenses technologies that could transform treatment of blood diseases, immune disorders

Magenta Therapeutics

The startup is cofounded by stem cell scientist Professor David Scadden. X

Convening Leaders in Science and Business

First annual Harvard FUSION symposium probes the future of regenerative medicine

Convergence

FUSION is hosted by OTD's Blavatnik Biomedical Accelerator and the Blavatnik Fellowship in Life Science Entrepreneurship at HBS. X

Advancing Science, Harnessing Innovation

Six-year, $8.4M research alliance with Tata companies pioneers a new model of technology development

Leadership Development

Tata Fellows at HBS will collaborate with Harvard research teams to develop commercialization plans for arising technologies. X

Visualizing Gene Expression In Situ

New startup to commercialize FISSEQ technology that sequences and maps thousands of RNAs within cells and tissues

The Next "Next-Gen" Sequencing

FISSEQ technology may advance the development of diagnostics and the discovery of new drug targets. X